(PharmaNewsWire.Com, September 09, 2017 ) Market Research Hub (MRH) has included the latest Forecast report titled “European ICU Sedation Drugs Market Size, Trends & Forecasts (2017-2021)”, to its vast database. The report provides analysis of Europe ICU sedation drugs market, with detailed analysis of market size and growth, and segmentation of the industry. The analysis of the European ICU sedation drugs market includes the market by value and by segments.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall the Europe ICU sedation drugs market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Aspen Pharmacare, Perrigo, Orion Corporation and Primex Pharmaceuticals are some of the key players operating in the Europe ICU sedation drugs market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Sedation is described as the action of reducing apprehension, stress, irritability or excitement by administration of a sedative agent or drug. A sedative is a medication that commonly induces into nervous system to calm and to relax. Significantly, sedation is utilized as a part of minor surgeries like dentistry, some corrective surgeries or to deal with high tension patients. Sedation is accomplished along a continuum of sedation levels: minimal sedation, moderate sedation, deep sedation and general anesthesia.
The pathway by which a medicine or liquid is entered into the body is called as route of administration. Sedatives are administered through various medium namely; inhalation, tablets, injections, or Intravenous (IVs). Commonly used route of administration are Intravenous (IVs) and Inhalation.
An intravenous route used a venipuncture as a means of injecting central nervous system depressants into the bloodstream. The major intravenous anesthetic drugs are: Remifentanil, Midazolam, Propofol and Dexmedetomidine
An inhalational sedation uses inhalable route of administration, through an anesthesia mask, laryngeal mask airway or tracheal tube connected to an anesthetic and an anesthetic delivery system like AnaConDa and Mirus. The major inhalational sedation or anesthetic agents that uses inhalable route of administration are: Sevoflurane, Isoflurane and Desflurane.
The Europe ICU sedation drugs market is expected to increase at high growth rates during the forecasted period (2017-2021). The Europe ICU sedation drugs market is supported by various growth drivers, rising geriatric population, adoption of sedentary lifestyle, increasing number of surgeries, increasing healthcare expenditure, etc. Some challenges that hinder the growth are adverse effects of sedative drugs, lack of trained healthcare providers and environmental issues, etc. Table of Content: 1. Executive Summary
2. Introduction
2.1 Sedation: An Overview 2.2 ICU Sedation Drugs Routes of Administration
2.3 Advantages & Disadvantages of ICU Sedation Drugs
2.3.1 Advantages 2.3.2 Disadvantages
3. Europe Market Analysis
3.1 Europe ICU Sedation Drugs Market: An Overview
3.1.1 Europe ICU Sedation Drugs Market by Value 3.1.2 Europe ICU Sedation Drugs Market by Segment
3.2 Europe ICU Sedation Drug Market: Segment Analysis
3.2.1 Europe Propofol ICU Sedation Drug Market by Value 3.2.2 Europe Dexmedetomidine ICU Sedation Drugs Market by Value 3.2.3 Europe Midazolam ICU Sedation Drugs Market by Value 3.2.4 Europe Remifentanil ICU Sedation Drugs Market by Value
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
